Richard J. Lim is a life science professional with experience in biotech corporate development and venture capital. He has held leadership roles at several investment firms and biopharmaceutical companies.
At firms with a similar stage, sector and check size.
One email when Richard's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRichard J. Lim is a life science professional with experience in biotech corporate development and venture capital. He has held leadership roles at several investment firms and biopharmaceutical companies.
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Richard in the subject. A warm intro from a founder Cure Ventures backed works better.
Engagement Manager at LEK Consulting; Vice President at Saunders Karp & Megrue; Managing Director at MVM Life Science Partners LLP; Managing Member and President at Omega Funds; Chief Business Officer and SVP of Corporate Development at an oncology focused biopharmaceutical company.
Last updated 2026-10-15. Is this you? Ask for a correction.